Publications
Academic article
- Johannes Jernqvist Gaare; Christian Dölle; Brage Brakedal et al. (2023). Nicotinamide riboside supplementation is not associated with altered methylation homeostasis in Parkinson's disease. (external link)
- Brage Brakedal; Charalampos Tzoulis; Ole-Bjørn Tysnes et al. (2021). NSAID use is not associated with Parkinson's disease incidence: A Norwegian Prescription Database study. (external link)
- Brage Brakedal; Irene Hana Flønes; Simone B. C. Frizell Reiter et al. (2017). Glitazone use associated with reduced risk of Parkinson's disease. (external link)
- Brage Brakedal; Ole-Bjørn Tysnes; Geir Olve Skeie et al. (2014). The factor structure of the UPDRS motor scores changes during early Parkinson's disease. (external link)
- Irene Hana Flønes; Erika Fernandez-Vizarra; Maria Lykouri et al. (2017). Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. (external link)
- Brage Brakedal; Christian Dölle; Frank Riemer et al. (2022). The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease. (external link)
- Simon Ulvenes Kverneng; Kjersti Eline Stige; Haakon Berven et al. (2025). Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease. (external link)
- Brage Brakedal; Lilah Toker; Kristoffer Haugarvoll et al. (2022). A nationwide study of the incidence, prevalence and mortality of Parkinson’s disease in the Norwegian population. (external link)